DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹8,547 Cr | ₹7,933 Cr | ₹6,349 Cr | ₹3,767 Cr | ₹3,870 Cr |
What is the latest Operating Profit of DR REDDYS LABORATORIES ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹8,547 Cr |
| Mar2025 | ₹7,933 Cr |
| Mar2024 | ₹6,349 Cr |
| Mar2023 | ₹3,767 Cr |
| Mar2022 | ₹3,870 Cr |
How is Operating Profit of DR REDDYS LABORATORIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,547 Cr | 7.74 | |
| Mar2025 | ₹7,933 Cr | 24.95 | |
| Mar2024 | ₹6,349 Cr | 68.52 | |
| Mar2023 | ₹3,767 Cr | -2.65 | |
| Mar2022 | ₹3,870 Cr | - | |
Compare Operating Profit of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹115,689.1 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
| MANKIND PHARMA | ₹109,911.0 Cr | 4% | 7.5% | 5.8% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | -0.1% |
16% |
14.6% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses